Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• By broadening sensor and insulin options for the MiniMed 780G system, more people will benefit from automated insulin delivery that supports easier mealtimes, greater flexibility, and more confident diabetes management

  80% confidence

• Instinct sensor offers up to 15 days of wear and is the world's smallest and thinnest integrated CGM

  80% confidence

• Ultra rapid-acting insulin's faster onset may help reduce the impact of late or missed meal doses, allowing the insulin to catch up more effectively

  80% confidence

• Anyone who requires insulin therapy to manage their diabetes, whether type 1 or type 2, can benefit from automated insulin delivery

  80% confidence

• MiniMed 780G system automatically adjusts insulin delivery every five minutes, responding to glucose changes, supporting more stable glucose control with fewer highs and lows and less daily decision-making

  80% confidence

• These milestones reflect unwavering commitment to expanding access and giving individuals living with diabetes more choice in how they manage their condition

  80% confidence

• More people living with type 2 diabetes will get access to life-changing technology improving their day-to-day experience in managing their diabetes

  80% confidence

• Bringing together the Instinct sensor with the well-established algorithm of the MiniMed 780G system makes for an extremely effective combination

  80% confidence

• Medtronic technologies and therapies treat 70 health conditions and transform the lives of two people every second, every hour, every day

  80% confidence